The post USD/MXN jumps above 17.70 as Middle East war spurs risk-off appeared on BitcoinEthereumNews.com. The Mexican Peso (MXN) depreciates sharply on ThursdayThe post USD/MXN jumps above 17.70 as Middle East war spurs risk-off appeared on BitcoinEthereumNews.com. The Mexican Peso (MXN) depreciates sharply on Thursday

USD/MXN jumps above 17.70 as Middle East war spurs risk-off

For feedback or concerns regarding this content, please contact us at [email protected]

The Mexican Peso (MXN) depreciates sharply on Thursday as hostilities intensify in the Middle East, triggering a flight to safety, which underpinned the US Dollar (USD). Additionally, solid jobs data in the US decreased the chances that the Federal Reserve (Fed) might cut rates twice this year. At the time of writing, the USD/MXN pair trades at 17.72, up more than 0.95%.

Flight to safety and strong US jobs data pressure the Mexican Peso

Market mood remains dismal as the US–Iran conflict entered its sixth day with no signs of a de-escalation. Tehran forces attacked two vessels on Thursday, while US President Donald Trump rejected the son of the Ayatollah to lead Iran.

Trump added that he would be involved in deciding Iran’s new leadership, Axios reported, while sirens heard in multiple Gulf nations paint a gloomy geopolitical scenario, which favors further US Dollar appreciation to the detriment of the Mexican currency.

The US Labor Department reported that Initial Jobless Claims totaled 213K for the week ending February 28, below the expected 215K, suggesting ongoing strength in the labor market.

Data from Challenger, Gray & Christmas indicated that announced layoffs dropped to 48,300 in February, a 55% decrease from January’s 108,435. Digging into the report, hiring plans soared 140% from January but were down 63% compared to last February.

Investors trimmed Fed dovish bets

Following the data, Richmond Fed President Thomas Barkin said inflation remains sticky and that recent labor market data was solid. He added that the balance of risks could change as recent inflation data raises questions about whether the central bank has fully won the battle against higher prices.

Money markets had priced in a less-dovish Fed, according to Prime Market Terminal data. A day ago, traders priced in 40 basis points (bps) of easing towards the year’s end, but it fell to 35 bps as of writing.

The Fed Beige Book highlighted those economic expectations “were optimistic” with most districts expecting “moderate growth.” Regarding the labor market, officials find conditions “generally stable,” yet the low-hiring, low-firing scenario persists.

Across the southern border, Gross Fixed Investment in Mexico was unchanged in December, after a -6.5% decline in November, but exceeded forecasts for a 2.8% drop, and was 0.5%, little changed.

Next week, traders will eye the release of Mexican inflation figures. In the US, Friday’s Nonfarm Payrolls for February is awaited, along with the unemployment rate.

USD/MXN Price Forecast: Downtrend intact unless bulls reclaim 18.00

The USD/MXN technical picture is mixed. Although price action is respecting the market structure of lower-highs and lower-lows, the break of a resistance trendline drawn from around April’s 2025 highs near 21.07 broke on March 3, increasing speculation of an upward correction.

The Relative Strength Index (RSI) has been bullish, after spending time below its 50-neutral level since the end of November 2025, a sign that sellers are losing some strength. In addition to this, if the index clears the latest peak at 64.88, it will mean that buyers are stepping in.

For a bullish resumption, traders must clear the 100-day SMA at 17.90. If surpassed, the next key resistance is 18.00, followed by the 200-day SMA at 18.30. Downwards lies the 50- and 20-day SMAs, each at 17.49 and 17.26, respectively. On further weakness, the 17.00 figure is up next.

USD/MXN Daily Chart

Mexican Peso FAQs

The Mexican Peso (MXN) is the most traded currency among its Latin American peers. Its value is broadly determined by the performance of the Mexican economy, the country’s central bank’s policy, the amount of foreign investment in the country and even the levels of remittances sent by Mexicans who live abroad, particularly in the United States. Geopolitical trends can also move MXN: for example, the process of nearshoring – or the decision by some firms to relocate manufacturing capacity and supply chains closer to their home countries – is also seen as a catalyst for the Mexican currency as the country is considered a key manufacturing hub in the American continent. Another catalyst for MXN is Oil prices as Mexico is a key exporter of the commodity.

The main objective of Mexico’s central bank, also known as Banxico, is to maintain inflation at low and stable levels (at or close to its target of 3%, the midpoint in a tolerance band of between 2% and 4%). To this end, the bank sets an appropriate level of interest rates. When inflation is too high, Banxico will attempt to tame it by raising interest rates, making it more expensive for households and businesses to borrow money, thus cooling demand and the overall economy. Higher interest rates are generally positive for the Mexican Peso (MXN) as they lead to higher yields, making the country a more attractive place for investors. On the contrary, lower interest rates tend to weaken MXN.

Macroeconomic data releases are key to assess the state of the economy and can have an impact on the Mexican Peso (MXN) valuation. A strong Mexican economy, based on high economic growth, low unemployment and high confidence is good for MXN. Not only does it attract more foreign investment but it may encourage the Bank of Mexico (Banxico) to increase interest rates, particularly if this strength comes together with elevated inflation. However, if economic data is weak, MXN is likely to depreciate.

As an emerging-market currency, the Mexican Peso (MXN) tends to strive during risk-on periods, or when investors perceive that broader market risks are low and thus are eager to engage with investments that carry a higher risk. Conversely, MXN tends to weaken at times of market turbulence or economic uncertainty as investors tend to sell higher-risk assets and flee to the more-stable safe havens.

Source: https://www.fxstreet.com/news/usd-mxn-jumps-above-1770-as-middle-east-war-spurs-risk-off-202603052025

Market Opportunity
MXN Logo
MXN Price(MXN)
$0.05394
$0.05394$0.05394
-0.18%
USD
MXN (MXN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09